JFGIW
JAZZ icon

Johnson Financial Group Inc (Wisconsin)’s Jazz Pharmaceuticals JAZZ Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8
Closed -$854 – 979
2024
Q2 		$854 Buy
+8
New +$880 ﹤0.01% 759
2024
Q1 		– Sell
-3
Closed -$369 – 889
2023
Q4 		$369 Buy
+3
New +$374 ﹤0.01% 848
2013
Q3 		– Sell
-84
Closed -$6K – 690
2013
Q2 		$6K Buy
+84
New +$5.13K ﹤0.01% 603

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s JAZZ Position: Q3 2024 in Review

Johnson Financial Group Inc (Wisconsin) sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2024, closing a stake of 8 shares — an estimated $854 sold.

Johnson Financial Group Inc (Wisconsin) first reported a position in JAZZ in Q2 2013 and held it in 3 quarters. The position peaked at $6K in Q2 2013. 477 funds tracked by Wall St. Rank hold JAZZ as of Q3 2024.

  • Johnson Financial Group Inc (Wisconsin) reported no remaining Jazz Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Johnson Financial Group Inc (Wisconsin) sold 8 Jazz Pharmaceuticals shares in Q3 2024, an estimated $854.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 3 quarters.
  • Johnson Financial Group Inc (Wisconsin)'s Jazz Pharmaceuticals position peaked at $6K in Q2 2013.
  • 477 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2024.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q3 2024, filed 13 Nov 2024.